Codar AR and Daclizumab Subcutaneous
Determining the interaction of Codar AR and Daclizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: chlorpheniramine / codeine
Brand name: Codar AR, Tuzistra XR, Codeprex, Cotab A, Cotab AX, Notuss-AC, Z-Tuss AC, Zodryl AC 25, Zodryl AC 30, Zodryl AC 35, Zodryl AC 50, Zodryl AC 40, Zodryl AC 60, Zodryl AC 80, EndaCof-C, TL-Hist CM, Zodryl AC Adult, Lexuss 210, EndaCof-C, Tuxarin ER
Synonyms: n.a.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Codar AR-Dacogen
- Codar AR-Dacomitinib
- Codar AR-Dactinomycin
- Codar AR-Dactinomycin Injection
- Codar AR-Dactinomycin Intravenous
- Codar AR-Daklinza
- Daclizumab Subcutaneous-Codar D
- Daclizumab Subcutaneous-Codar GF
- Daclizumab Subcutaneous-Codeine
- Daclizumab Subcutaneous-Codeine and Chlorpheniramine
- Daclizumab Subcutaneous-Codeine and Chlorpheniramine ER Tablets
- Daclizumab Subcutaneous-Codeine and Chlorpheniramine Extended-Release Suspension